SEC Comment Letter 0000000000-23-006297 to INTELLIGENT BIO SOLUTIONS INC. (INBS)

INTELLIGENT BIO SOLUTIONS INC.
Date: June 12, 2023 · CIK: 0001725430 · Accession: 0000000000-23-006297

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-272463

Date

June 12, 2023

Author

Harry Simeonidis

Form

UPLOAD

Company

INTELLIGENT BIO SOLUTIONS INC.

Letter

United States securities and exchange commission logo June 12, 2023 Harry Simeonidis Chief Executive Officer and President Intelligent Bio Solutions Inc. 142 West 57th Street, 11th Floor New York, New York 10019 Re:Intelligent Bio Solutions Inc. Registration Statement on Form S-1 Filed June 6, 2023 File No. 333-272463 Dear Harry Simeonidis: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Johnathan C. Duncan, Esq.

Show Raw Text

United States securities and exchange commission logo
June 12, 2023
Harry Simeonidis
Chief Executive Officer and President
Intelligent Bio Solutions Inc.
142 West 57th Street, 11th Floor
New York, New York 10019
Re:Intelligent Bio Solutions Inc.
Registration Statement on Form S-1
Filed June 6, 2023
File No. 333-272463
Dear Harry Simeonidis:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Johnathan C. Duncan, Esq.

SecProbe.io